Karin Ann Thacker
General Counsel bei SENTI BIOSCIENCES, INC.
Profil
Karin Ann Thacker is currently the Vice President-Quality & Regulatory Affairs at Senti Biosciences, Inc. She previously worked as the Senior Director & Head-Regulatory Development at Puma Biotechnology, Inc. from 2015 to 2016.
From 2020 to 2022, she served as the VP-Regulatory Affairs & Quality Assurance at Harpoon Therapeutics, Inc. Prior to that, she was the Vice President-Global Regulatory Affairs at Gritstone bio, Inc. from 2016 to 2020.
Ms. Thacker completed her undergraduate and graduate degrees at the University of Manitoba.
Aktive Positionen von Karin Ann Thacker
| Unternehmen | Position | Beginn |
|---|---|---|
| SENTI BIOSCIENCES, INC. | General Counsel | - |
Ehemalige bekannte Positionen von Karin Ann Thacker
| Unternehmen | Position | Ende |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | General Counsel | 01.08.2022 |
| GRITSTONE BIO, INC. | General Counsel | 01.08.2020 |
| PUMA BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01.05.2016 |
Ausbildung von Karin Ann Thacker
| University of Manitoba | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| GRITSTONE BIO, INC. | Health Technology |
| HARPOON THERAPEUTICS, INC. | Health Technology |
| SENTI BIOSCIENCES, INC. | Health Technology |
